GANNON STEVEN bought XENE
May 12, 2026 · Form 4 insider transaction
GANNON STEVEN bought 3,500 shares of Xenon Pharmaceuticals Inc. at $7.38 per share, a transaction worth $25.8K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
3,500
Price
$7.38
Total value
$25.8K
InsiderGANNON STEVEN
RoleDirector
SecurityCommon Shares
Transaction codeM: Option exercise
Transaction dateMay 12, 2026
Filing dateMay 13, 2026
Shares owned after10,641
OwnershipDirect
10b5-1 planNo
AmendedNo